Non-coding RNAs and regulation of the PI3K signaling pathway in lung cancer: Recent insights and potential clinical applications
Open Access
- 1 April 2025
- journal article
- review article
- Published by KEAI Publishing in Non-coding RNA Research
- Vol. 11, 1-21
Abstract
Lung cancer (LC) is one of the most common causes of cancer-related death worldwide. It has been demonstrated that the prognosis of current drug treatments is affected by a variety of factors, including late stage, tumor recurrence, inaccessibility to appropriate treatments, and, most importantly, chemotherapy resistance. Non-coding RNAs (ncRNAs) contribute to tumor development, with some acting as tumor suppressors and others as oncogenes. The phosphoinositide 3-kinase (PI3Ks)/AKT serine/threonine kinase pathway is one of the most important common targets of ncRNAs in cancer, which is widely applied to modulate the cell cycle and a variety of biological processes, including cell growth, mobility survival, metabolic activity, and protein production. Discovering the biology of ncRNA-PI3K/AKT signaling may lead to advances in cancer diagnosis and treatment. As a result, we investigated the expression and role of PI3K/AKT-related ncRNAs in clinical characteristics of lung cancer, as well as their functions as potential biomarkers in lung cancer diagnosis, prognosis, and treatment.Keywords
This publication has 344 references indexed in Scilit:
- Circulating TP73‐AS1 and CRNDE serve as diagnostic and prognostic biomarkers for non‐small cell lung cancerCancer Medicine, 2022
- Overexpression of long noncoding RNA HOXA‐AS2 predicts an adverse prognosis and promotes tumorigenesis via SOX4/PI3K/AKT pathway in acute myeloid leukemiaCell Biology International, 2020
- lncRNA HOXB‐AS3 exacerbates proliferation, migration, and invasion of lung cancer via activating the PI3K‐AKT pathwayJournal of Cellular Physiology, 2020
- Long noncoding RNA TCL6 binds to miR‐106a‐5p to regulate hepatocellular carcinoma cells through PI3K/AKT signaling pathwayJournal of Cellular Physiology, 2020
- Role of regulatory miRNAs of the PI3K/AKT/mTOR signaling in the pathogenesis of hepatocellular carcinomaJournal of Cellular Physiology, 2019
- MicroRNAs associated with lung squamous cell carcinoma: New prognostic biomarkers and therapeutic targetsJournal of Cellular Biochemistry, 2019
- NAD(P)H Quinone Dehydrogenase 1 Ablation Inhibits Activation of the Phosphoinositide 3‐Kinase/Akt Serine/Threonine Kinase and Mitogen‐Activated Protein Kinase/Extracellular Signal‐Regulated Kinase Pathways and Blocks Metabolic Adaptation in Hepatocellular CarcinomaHepatology, 2019
- Long noncoding RNA H19 competitively binds miR‐93‐5p to regulate STAT3 expression in breast cancerJournal of Cellular Biochemistry, 2018
- MiR‐503 targets PI3K p85 and IKK‐β and suppresses progression of non‐small cell lung cancerInternational Journal of Cancer, 2014
- MMP‐2 alters VEGF expression via αVβ3 integrin‐mediated PI3K/AKT signaling in A549 lung cancer cellsInternational Journal of Cancer, 2010